Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA HEALTH CLAIM FINAL RULE STAY-OF-ACTION SOUGHT

This article was originally published in The Tan Sheet

Executive Summary

FDA HEALTH CLAIM FINAL RULE STAY-OF-ACTION SOUGHT by a coalition including the American Preventive Medical Association, Citizens for Health, National Health Federation, and supplement manufacturers Durk Pearson and Sandy Shaw. In a Jan. 21 petition to FDA submitted by counsel Jonathan Emord (Silver Spring, Md. law firm Alexander, Gebhardt, Aponte & Marks), the group insisted that the agency's Jan. 4 final rule disallowing health claims for five nutrient-disease relationships ("The Tan Sheet" Jan. 3, p. 7) violates First Amendment rights and therefore should be stayed.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082453

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel